These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28610781)

  • 41. The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.
    Brennan MJ; Tanner R; Morris S; Scriba TJ; Achkar JM; Zelmer A; Hokey DA; Izzo A; Sharpe S; Williams A; Penn-Nicholson A; Erasmus M; Stylianou E; Hoft DF; McShane H; Fletcher HA
    Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28701467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can colony-forming unit testing be used to extend the shelf life of BCG vaccines?
    Messina NL; Germano S; Bonnici R; Lee LY; Daley AJ; Bustamante A; Jelfs P; Curtis N
    Tuberculosis (Edinb); 2018 Jul; 111():188-192. PubMed ID: 30029906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.
    Gröschel MI; Sayes F; Shin SJ; Frigui W; Pawlik A; Orgeur M; Canetti R; Honoré N; Simeone R; van der Werf TS; Bitter W; Cho SN; Majlessi L; Brosch R
    Cell Rep; 2017 Mar; 18(11):2752-2765. PubMed ID: 28297677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
    Shi CH; Zhang TF; Zhu DS; Zhang H; Bai B; Zhao Y; Yue CL; Zhao L; Liu JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):603-7. PubMed ID: 19958680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against mycobacterial infection: A case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure.
    Basu Roy R; Sambou B; Sissoko M; Holder B; Gomez MP; Egere U; Sillah AK; Koukounari A; Kampmann B
    EBioMedicine; 2020 Sep; 59():102891. PubMed ID: 32675024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.
    Zhang M; Dong C; Xiong S
    Hum Vaccin Immunother; 2017 Apr; 13(4):816-822. PubMed ID: 27960596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.
    Kremer K; van-der-Werf MJ; Au BK; Anh DD; Kam KM; van-Doorn HR; Borgdorff MW; van-Soolingen D
    Emerg Infect Dis; 2009 Feb; 15(2):335-9. PubMed ID: 19193289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults.
    Boer MC; van Meijgaarden KE; Goletti D; Vanini V; Prins C; Ottenhoff TH; Joosten SA
    Tuberculosis (Edinb); 2016 Mar; 97():163-71. PubMed ID: 26750180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple consecutive infections might explain the lack of protection by BCG.
    Cardona PJ; Vilaplana C
    PLoS One; 2014; 9(4):e94736. PubMed ID: 24740286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of human newborn BCG immunization on monocyte viability and function at 3 months of age.
    Sepulveda RL; Arredondo S; Rodriguez E; Gonzalez B; Leiva LE; Sorensen RU
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):122-7. PubMed ID: 9441075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats.
    Vidal E; Arrieta-Villegas C; Grasa M; Mercader I; Domingo M; Pérez de Val B
    BMC Vet Res; 2017 Aug; 13(1):252. PubMed ID: 28818102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination of mice with recombinant bacille Calmette-Guérin harboring Rv1357c protects similarly to native BCG.
    Flores-Valdez MA; Aceves-Sánchez MJ; Montero-Pérez SA; Sánchez-López AD; Gutiérrez-Pabello JA; Hernández-Pando R
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):774-6. PubMed ID: 22507759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.
    Hoft DF; Blazevic A; Abate G; Hanekom WA; Kaplan G; Soler JH; Weichold F; Geiter L; Sadoff JC; Horwitz MA
    J Infect Dis; 2008 Nov; 198(10):1491-501. PubMed ID: 18808333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
    Vipond J; Vipond R; Allen-Vercoe E; Clark SO; Hatch GJ; Gooch KE; Bacon J; Hampshire T; Shuttleworth H; Minton NP; Blake K; Williams A; Marsh PD
    Vaccine; 2006 Sep; 24(37-39):6340-50. PubMed ID: 16781800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.